| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Case Report |
| Article Title |
Pancreaticoduodenectomy after neoadjuvant chemotherapy for gastric cancer invading the pancreatic head: A case report
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Masahiro Yura, Kiminori Takano, Kiyohiko Adachi, Asuka Hara, Keita Hayashi, Yuki Tajima, Yasushi Kaneko, Yoichiro Ikoma, Hiroto Fujisaki, Akira Hirata, Kumiko Hongo, Kikuo Yo, Kimiyasu Yoneyama, Reiko Dehari, Kazuo Koyanagi and Motohito Nakagawa |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Masahiro Yura, MD, Doctor, Surgeon, Department of Surgery, Hiratsuka City Hospital, 1-19-1, Mihamihara, Hiratsuka 2540065, Kanagawa, Japan. myura@ncc.go.jp |
| Key Words |
Pancreaticoduodenectomy; Gastric cancer; Neoadjuvant chemotherapy; Trastuzumab; Human epithelial factor receptor 2; Case report |
| Core Tip |
Because of the high surgical risk and poor prognosis, pancreaticoduodenectomy (PD) is rarely performed for gastric cancer. However, due to advances in surgery and improvements in perioperative management, PD may be considered for gastric cancer to improve long-term survival. We present the successful case of radical resection with PD after neoadjuvant chemotherapy combined with trastuzumab for human epithelial factor receptor 2-positive locally advanced gastric cancer invading the pancreatic head without postoperative severe complication. This case suggests that radical resection with PD after neoadjuvant chemotherapy combined with trastuzumab is an option for locally advanced human epithelial factor receptor 2-positive gastric cancer invading the pancreatic head in the absence of non-curative factors. |
| Publish Date |
2021-02-05 10:20 |
| Citation |
Yura M, Takano K, Adachi K, Hara A, Hayashi K, Tajima Y, Kaneko Y, Ikoma Y, Fujisaki H, Hirata A, Hongo K, Yo K, Yoneyama K, Dehari R, Koyanagi K, Nakagawa M. Pancreaticoduodenectomy after neoadjuvant chemotherapy for gastric cancer invading the pancreatic head: A case report. World J Gastroenterol 2021; 27(6): 534-544 |
| URL |
https://www.wjgnet.com/1007-9327/full/v27/i6/534.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v27.i6.534 |
